Anti-antibiotics

July 22, 2013
Two scenarios of antimicrobial peptide action: (top) an antimicrobial peptide binds to microbial membranes and forms membrane-disrupting helical structures or (bottom) when challenged by an anti-antimicrobial peptide it forms a biologically inert helical complex

Antimicrobial peptides are natural antibiotics found in all multicellular organisms. These molecules are viewed as potential drug candidates in the post-antibiotic era because widespread microbial resistance against them has yet to emerge.

The use of these peptides in medicine may trigger the development of antimicrobial resistance in a fashion similar to that currently occurring with more conventional antibiotics such as methicillin and vancomycin. However, the mechanism of action of , which target and rapidly destroy bacterial membranes, lends credibility to the view that this is unlikely to happen. To acquire resistance against such formidable agents, microorganisms would need to re-build their genetic apparatus, which is an extremely high price to pay.

In a recent study, a research team comprising scientists from NPL, University of Bristol, University of Edinburgh, University of Oxford and IBM explored the effect of designed to be antagonistic towards antimicrobial peptides. The research showed that these 'anti-antimicrobial' sequences interact with the antimicrobial peptides to form inert molecular complexes, known as helical oligomers.

The team then studied the structural and biological properties of these inert assemblies in biologically relevant environments, using a combination of spectroscopy, microscopy, bioassays and . The findings, reported in the Journal of Biological Chemistry, suggest that antagonistic sequences secreted by bacterial cells or expressed on their surfaces may cause efficient anti-antimicrobial responses. Although this remains to be shown in nature, this research offers a molecular rationale for these responses with potential implications for antimicrobial resistance.

Lloyd Ryan, an NPL research scientist who worked on the project, said:

"It is widely believed that antimicrobial peptides are powerful antibiotics that can overcome the we see nowadays in clinics. However, for us it was important to understand if a relatively simple mechanism of resistance is plausible against antimicrobial peptides before they are considered for use on an industrial scale."

More information: www.jbc.org/content/288/28/20162.long

Related Stories

Do it like the immune system: novel antimicrobials

August 30, 2012

Microbial infections are becoming unbeatable due to progressive mutations that lead to antimicrobial drug resistance. European scientists exploited the characteristics of novel antimicrobial compounds that mimic the dual ...

Antimicrobial resistance in Vietnam

May 7, 2013

Heiman Wertheim and Arjun Chandna from Oxford University and colleagues describe the launch and impact of VINARES, an initiative to strengthen antimicrobial stewardship in Viet Nam, which may be instructive for other countries ...

Recommended for you

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.